
William W. Moore
Examiner (ID: 8599, Phone: (571)272-0933 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1814, 1656, 1805, 1652 |
| Total Applications | 1409 |
| Issued Applications | 808 |
| Pending Applications | 131 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6566882
[patent_doc_number] => 20100234300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'PROAEROLYSIN CONTAINING PROTEASE ACTIVATION SEQUENCES AND METHODS OF USE FOR TREATMENT OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/788913
[patent_app_country] => US
[patent_app_date] => 2010-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22387
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12788913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/788913 | Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer | May 26, 2010 | Issued |
Array
(
[id] => 6126678
[patent_doc_number] => 20110086412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Multiply-Substituted Protease Variants'
[patent_app_type] => utility
[patent_app_number] => 12/776932
[patent_app_country] => US
[patent_app_date] => 2010-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14452
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776932 | Multiply-Substituted Protease Variants | May 9, 2010 | Abandoned |
Array
(
[id] => 6038909
[patent_doc_number] => 20110091958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Multiply-Substituted Protease Variants'
[patent_app_type] => utility
[patent_app_number] => 12/776921
[patent_app_country] => US
[patent_app_date] => 2010-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14396
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091958.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776921 | Multiply-Substituted Protease Variants | May 9, 2010 | Abandoned |
Array
(
[id] => 6038910
[patent_doc_number] => 20110091959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Multiply-Substituted Protease Variants'
[patent_app_type] => utility
[patent_app_number] => 12/776940
[patent_app_country] => US
[patent_app_date] => 2010-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14400
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776940 | Multiply-Substituted Protease Variants | May 9, 2010 | Abandoned |
Array
(
[id] => 6466064
[patent_doc_number] => 20100281552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'SYNTHETIC OPLOPHORUS LUCIFERASES WITH ENHANCED LIGHT OUTPUT'
[patent_app_type] => utility
[patent_app_number] => 12/773002
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 17482
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20100281552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12773002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/773002 | Synthetic Oplophorus luciferases with enhanced light output | May 2, 2010 | Issued |
Array
(
[id] => 7670061
[patent_doc_number] => 20110319330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury'
[patent_app_type] => utility
[patent_app_number] => 12/767858
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6741
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12767858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/767858 | Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury | Apr 26, 2010 | Abandoned |
Array
(
[id] => 6323669
[patent_doc_number] => 20100196991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'NOVEL PROTEIN VARIANTS BY CIRCULAR PERMUTATION'
[patent_app_type] => utility
[patent_app_number] => 12/760581
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9828
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12760581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760581 | NOVEL PROTEIN VARIANTS BY CIRCULAR PERMUTATION | Apr 14, 2010 | Abandoned |
Array
(
[id] => 6188912
[patent_doc_number] => 20110171718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Proteases With Modified Pre-Pro Regions'
[patent_app_type] => utility
[patent_app_number] => 12/761253
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 30220
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12761253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/761253 | Proteases With Modified Pre-Pro Regions | Apr 14, 2010 | Abandoned |
Array
(
[id] => 5969007
[patent_doc_number] => 20110150860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'NOVEL 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 AND 49933 MOLECULES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/755449
[patent_app_country] => US
[patent_app_date] => 2010-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96881
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150860.pdf
[firstpage_image] =>[orig_patent_app_number] => 12755449
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/755449 | NOVEL 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 AND 49933 MOLECULES AND USES THEREFOR | Apr 6, 2010 | Abandoned |
Array
(
[id] => 9957743
[patent_doc_number] => 09005946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Variant endoglucanases and related polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 13/203909
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21084
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203909
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203909 | Variant endoglucanases and related polynucleotides | Mar 9, 2010 | Issued |
Array
(
[id] => 8955679
[patent_doc_number] => 08501450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Hepatitis C virus variants'
[patent_app_type] => utility
[patent_app_number] => 12/718340
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 24714
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12718340
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718340 | Hepatitis C virus variants | Mar 4, 2010 | Issued |
Array
(
[id] => 6091060
[patent_doc_number] => 20110218326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'PLANT-PROTEIN PRODUCT AND METHOD FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/716376
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2568
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716376 | PLANT-PROTEIN PRODUCT AND METHOD FOR PREPARING THE SAME | Mar 2, 2010 | Abandoned |
Array
(
[id] => 9648825
[patent_doc_number] => 08802836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Cloning and recombinant productions of Vespula venom protease and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/254644
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 39841
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254644 | Cloning and recombinant productions of Vespula venom protease and methods of use thereof | Mar 2, 2010 | Issued |
Array
(
[id] => 6430988
[patent_doc_number] => 20100152092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'SUBTILASES'
[patent_app_type] => utility
[patent_app_number] => 12/710502
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9600
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710502 | Subtilases | Feb 22, 2010 | Issued |
Array
(
[id] => 7662737
[patent_doc_number] => 20110312006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample'
[patent_app_type] => utility
[patent_app_number] => 13/148905
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16001
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312006.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148905 | Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample | Feb 9, 2010 | Abandoned |
Array
(
[id] => 6070722
[patent_doc_number] => 20110045572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY'
[patent_app_type] => utility
[patent_app_number] => 12/699979
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 74628
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12699979
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/699979 | PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY | Feb 3, 2010 | Abandoned |
Array
(
[id] => 6574296
[patent_doc_number] => 20100129343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface'
[patent_app_type] => utility
[patent_app_number] => 12/694788
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6600
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694788 | Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface | Jan 26, 2010 | Abandoned |
Array
(
[id] => 10097121
[patent_doc_number] => 09133423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Subtilase variants'
[patent_app_type] => utility
[patent_app_number] => 12/688057
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10098
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12688057
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688057 | Subtilase variants | Jan 14, 2010 | Issued |
Array
(
[id] => 6317107
[patent_doc_number] => 20100112598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Novel Assay for Inositol Phosphorylceramide Synthase Activity'
[patent_app_type] => utility
[patent_app_number] => 12/641435
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3953
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12641435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641435 | Novel Assay for Inositol Phosphorylceramide Synthase Activity | Dec 17, 2009 | Abandoned |
Array
(
[id] => 11583119
[patent_doc_number] => 09637746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Methods for control of flux in metabolic pathways'
[patent_app_type] => utility
[patent_app_number] => 13/132721
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9467
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132721
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132721 | Methods for control of flux in metabolic pathways | Dec 13, 2009 | Issued |